Fayez Sarofim & Co

Position in NAUT — Nautilus Biotechnology, Inc.

CIK 937729 Houston, TX

Position in NAUT

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$84,150

-$90,450 QoQ

Shares Held

45,000

0.0% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 93 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Fayez Sarofim & Co holds $7,172,383 across 4 Biotechnology names. NAUT ranks #4 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	10,000	$4,967,300
2	REGN	Regeneron Pharmaceuticals, Inc.	2,460	$1,533,908
3	HALO	Halozyme Therapeutics, Inc.	7,500	$587,025
4	NAUT	Nautilus Biotechnology, Inc. This page	45,000	$84,150

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$84,150	45,000	0.0%	Shares	Defined	2026-08-17
2026-03-31	$174,600	45,000	0.0%	Shares	Defined	2026-05-15
2025-12-31	$87,750	45,000	0.0%	Shares	Defined	2026-02-13
2025-09-30	$38,025	45,000	0.0%	Shares	Defined	2025-11-14
2025-06-30	$32,625	45,000	0.0%	Shares	Defined	2025-08-14
2025-03-31	$38,745	45,000	—	Shares	Defined	2025-05-12
No filing history on record for this holder in this stock.